Type and hit ENTER

RESEARCH AND DEVELOPMENT

Research and Development

ProAxsis are actively looking for co-development partners or collaborative projects in the field of protease biomarkers, target and compound validation.

Specialist Services

Bespoke Assay Development
Peptide-based inhibitor design and synthesis
Enzyme kinetics and compound characterisation
Activity-based steady state assays
SDS-PAGE and western blotting
ELISAs
Activity-based Immunoassays

ProAxsis

Follow Me

RT @ProfJDChalmers: Great to see neutrophil elastase and biomarker guided endotypes centre stage in the future of bronchiectasis management…

9 days ago

- ProAxsis

RT @ProfJDChalmers: We are delighted to publish the final results of the WILLOW trial of DPP1 inhibition in bronchiectasis in the @NEJM - t…

14 days ago

- ProAxsis

RT @ProfJDChalmers: We have known for many years that neutrophils are central to the pathophysiology of bronchiectasis, and neutrophil elas…

14 days ago

- ProAxsis

RT @InvestNI: Great news today for @QUB who has been granted significant funding from @UKRI_News Strength in Places Fund #innovation >> htt…

41 days ago

- ProAxsis

RESEARCH AND DEVELOPMENT | ProAxsis

RESEARCH AND DEVELOPMENT

Research and Development

Specialist Services

ProAxsis accelerates work on inflammatory biomarkers associated with COVID-19

ProAxsis investing in R&D to create new diagnostic tests for chronic human diseases

ProAxsis and the Connected Health Innovation Centre launch new partnership